Skip to main content
. 2020 Sep 20;22(12):1896–1903. doi: 10.1093/europace/euaa246

Table 2.

Risk factors for injury per patients

Population Size, n Injured, n Mean risk (CI) Relative risk (CI) P-value
Total 459 56 0.12 (0.10–0.15)
Sex
 Male 181 15 0.08 (0.05–0.13)
 Female 278 41 0.15 (0.11–0.19) 1.78 (1.02–3.12) 0.044
Age
 <Median 214 28 0.13 (0.09–0.18)
 >Median 245 28 0.11 (0.08–0.16) 0.87 (0.54–1.43) 0.32
Population type
 Bifascicular block 115 9 0.08 (0.04–0.14)
 Vasovagal 344 47 0.14 (0.10–0.18) 1.59 (0.81–3.14) 0.089
Prior year, n
 <Median 239 15 0.06 (0.04–0.10)
 >Median 220 41 0.19 (0.14–0.24) 2.97 (1.69–5.21) <0.0001
Prodrome
 Absent 61 15 0.25 (0.15–0.37)
 Present 28 11 0.39 (0.24–0.58) 1.60 (0.85–3.02) 0.075
Drug therapy
 Placebo 172 24 0.14 (0.10–0.20)
 Active 172 23 0.13 (0.09–0.19) 0.96 (0.56–1.63) 0.88

The mean age in the total study population was 45 and the median number of faints in the year before randomization was 3. Prodromal symptoms were recorded in POST 3 and 4. The bifascicular heart block population was in POST 3 and the vasovagal population was in POST 2 and 4.

CI, confidence interval.